We are live on ! Find out more
BIVI icon

BioVie
BIVI

14 hedge funds and large institutions have $7.45M invested in BioVie in 2021 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 3

8% more funds holding

Funds holding: 13 → 14 (+1)

0.01% more ownership

Funds ownership: 0.06% → 0.07% (+0.01%)

25% less capital invested

Capital invested by funds: $9.96M → $7.45M (-$2.51M)

Holders
14
Holders Change
+1
Holders Change %
+7.69%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
7
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
+$828K
2
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$136K
3
State Street
State Street
Massachusetts
+$85.5K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$61.2K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$54.3K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$355K
2
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$71K
3
Bank of America
Bank of America
North Carolina
-$7K

BIVI Hedge Fund Activity: Q4 2021 in Review

14 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in BioVie (BIVI) for Q4 2021, worth a combined $7.45M — down 25% from $9.96M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new BIVI positions and 3 closed out — a net gain of 1 holder — while 7 added to existing stakes and 0 trimmed.

The largest buyer was Sabby Management, adding an estimated $828K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $355K sold.

  • 14 institutional investors held BioVie (BIVI) as of Q4 2021, up from 13 in Q3 2021.
  • Funds reported $7.45M of BioVie stock for Q4 2021, down 25% quarter-over-quarter.
  • 4 funds opened new BioVie positions in Q4 2021 and 3 closed out, a net change of +1 holder.
  • The largest BioVie buyer in Q4 2021 was Sabby Management, an estimated $828K added.
  • The largest BioVie seller in Q4 2021 was Renaissance Technologies, an estimated $355K sold.

Based on aggregated 13F filings for Q4 2021.